PAIN THERAPEUTICS INC's ticker is PTIE and the CUSIP is 69562K100. A total of 46 filers reported holding PAIN THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $37,000 | -17.8% | 41,805 | -48.0% | 0.00% | – |
| Q4 2016 | $45,000 | -87.4% | 80,322 | -77.6% | 0.00% | – |
| Q3 2016 | $358,000 | +1054.8% | 357,962 | +2457.8% | 0.00% | – |
| Q1 2016 | $31,000 | +47.6% | 13,995 | +17.3% | 0.00% | – |
| Q4 2015 | $21,000 | -79.6% | 11,935 | -78.9% | 0.00% | – |
| Q3 2015 | $103,000 | -74.6% | 56,548 | -75.8% | 0.00% | – |
| Q2 2015 | $405,000 | +1660.9% | 234,104 | +1864.5% | 0.00% | – |
| Q1 2015 | $23,000 | -77.0% | 11,917 | -75.8% | 0.00% | – |
| Q4 2014 | $100,000 | -34.2% | 49,157 | +26.0% | 0.00% | – |
| Q3 2014 | $152,000 | -86.4% | 39,000 | -80.0% | 0.00% | – |
| Q2 2014 | $1,119,000 | -21.8% | 194,735 | -25.2% | 0.00% | – |
| Q1 2014 | $1,431,000 | +131.6% | 260,176 | +104.6% | 0.00% | – |
| Q4 2013 | $618,000 | +140.5% | 127,142 | +34.3% | 0.00% | – |
| Q3 2013 | $257,000 | -14.3% | 94,682 | -30.3% | 0.00% | – |
| Q2 2013 | $300,000 | – | 135,863 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Street Partners, LLC | 1,707,764 | $9,819,643,000 | 9.95% |
| SOPHROSYNE CAPITAL LLC | 951,362 | $5,472,000 | 5.57% |
| GREAT POINT PARTNERS LLC | 1,694,256 | $9,742,000 | 4.33% |
| INTREPID CAPITAL MANAGEMENT INC /DE/ | 436,148 | $2,508,000 | 2.19% |
| AVALON CAPITAL MANAGEMENT | 110,837 | $637,000 | 0.53% |
| Visium Asset Management, LP | 4,350,000 | $25,013,000 | 0.39% |
| Cheyne Capital Management (UK) LLP | 25,000 | $144,000 | 0.17% |
| Gruss Capital Management LP | 600,000 | $3,450,000 | 0.17% |
| Capital Impact Advisors, LLC | 31,206 | $179,000 | 0.14% |
| TFS CAPITAL LLC | 292,036 | $1,679,000 | 0.13% |